🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
4D Molecular Therapeutics, Inc. (FDMT)
NASDAQ: FDMT · Real-Time Price · USD
10.23
-0.49 (-4.57%)
Nov 20, 2026, 4:00 PM EST - Market closed

4D Molecular Therapeutics Balance Sheet

Millions USD. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
39.160.24149.34249.1152.35153
Short-Term Investments
267.89342.41275.5439.12161.294.78
Cash & Short-Term Investments
306.99402.66424.88288.23213.55247.78
Cash Growth
0.63%-5.23%47.41%34.97%-13.81%-10.46%
Accounts Receivable
-----0.05
Other Receivables
4.02----0.7
Receivables
4.02----0.75
Prepaid Expenses
11.2810.4810.068.366.967.76
Total Current Assets
322.29413.13434.93296.59220.51256.28
Property, Plant & Equipment
26.9833.0140.6131.6735.3528.95
Long-Term Investments
68.04111.3880.5810.954.9167.65
Other Long-Term Assets
11.449.194.260.681.080.6
Total Assets
428.75566.71560.38339.89261.85353.49

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Accounts Payable
7.8811.164.393.523.324.76
Accrued Expenses
35.2126.8718.8712.018.877.74
Current Portion of Leases
5.315.595.643.152.661.23
Current Unearned Revenue
3.990.360.260.270.882.6
Total Current Liabilities
52.3943.9929.1518.9515.7316.34
Long-Term Leases
13.4215.8218.9711.5213.4715.22
Long-Term Unearned Revenue
2.830.751.060.971.082.49
Other Long-Term Liabilities
2.480.50.60.620.230.33
Total Liabilities
90.8161.0549.7832.0630.5134.38

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Common Stock
0.010.010.01000
Additional Paid-In Capital
1,2751,2211,087723.14547.02526.52
Retained Earnings
-936.06-716.3-576.2-415.33-314.49-207
Comprehensive Income & Other
-1.010.730.230.02-1.2-0.42
Total Common Equity
337.94505.66510.61307.83231.34319.11
Shareholders' Equity
337.94505.66510.61307.83231.34319.11
Total Liabilities & Equity
428.75566.71560.38339.89261.85353.49

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Total Debt
38.4121.4124.6114.6716.1216.45
Net Cash (Debt)
336.62492.62480.85284.52202.34298.98
Net Cash Growth
-3.81%2.45%69.01%40.61%-32.32%8.04%
Net Cash Per Share
4.908.508.917.276.2510.78
Filing Date Shares Outstanding
56.3851.0546.349.7833.2332.24
Total Common Shares Outstanding
56.3757.6145.7943.0832.6332.22
Working Capital
269.89369.15405.78277.64204.78239.94
Book Value Per Share
5.998.7811.157.157.099.90
Tangible Book Value
337.94505.66510.61307.83231.34319.11
Tangible Book Value Per Share
5.998.7811.157.157.099.90
Machinery
17.117.6817.1714.6112.617.12
Construction In Progress
--1.180.550.4810.07
Leasehold Improvements
18.4718.4717.7616.916.92.53
SEC Filings: 10-K · 10-Q